Study S000348

GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record Study Protocol and Statistical Analysis Plan (PDF)

Registration

Registration: NCT03029351
Acronym: 1981
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: QUADRUPLE
Status: TERMINATED
Enrollment: 15
Start: 2017-01-10
Primary completion: 2019-07
Lead sponsor: University at Buffalo
Conditions: Type2 Diabetes; Kidney Diseases
Interventions: DRUG:Exenatide Extended Release for Inj Susp 2 MG; DRUG:Placebo
Results posted: TRUE
Individual participant data sharing: NO

Registered primary outcomes

Change From Baseline in Urinary Albuminuria Levels [baseline and 52 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.